Search research articles
Contact Us
Filters
Showing results (11-20 of 109) with videos related to
Page
of 11
Sort By:
European Journal of Heart Failure
|
December 5, 2019
It is time for consistency in the use of biomarkers in heart failure clinical trials
James L Januzzi, Nasrien E Ibrahim
Journal of the American College of Cardiology
|
July 21, 2018
Are Guidelines Merely Suggestions?
John L Jefferies, Nasrien E Ibrahim
Current Heart Failure Reports
|
February 23, 2018
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study
Nasrien E Ibrahim, James L Januzzi
Journal of the American College of Cardiology
|
July 4, 2020
The Need to Innovate and Accelerate Clinical Trial Performance: BeAT the Clock
James L Januzzi, Nasrien E Ibrahim
JACC. Heart Failure
|
February 4, 2022
Personalizing Comprehensive Disease-Modifying Therapy: Obstacles and Opportunities
Ankeet S Bhatt, Muthiah Vaduganathan, Nasrien E Ibrahim
JACC. Cardiovascular Interventions
|
March 25, 2022
In Search of Cardiogenic Shock Equity, Equality, and Justice…
Alexander G Truesdell, Araba Ofosu-Somuah, Nasrien E Ibrahim
JACC. Heart Failure
|
May 8, 2024
The Quagmire of Prognostication in Heart Failure: The Case for Equity Through Modeled Predictions
Christy N Taylor, Nasrien E Ibrahim, Quentin R Youmans
JACC. Heart Failure
|
January 1, 2021
Promoting Health Equity in Heart Failure Amid a Pandemic
Ersilia M DeFilippis, Mitchell A Psotka, Nasrien E Ibrahim
Journal of Clinical Medicine
|
October 27, 2022
Physicians' Considerations and Practice Recommendations Regarding the Use of Sodium-Glucose Cotransporter-2 Inhibitors
Serge A Jabbour, Nasrien E Ibrahim, Christos P Argyropoulos
JAMA
|
August 5, 2020
Heart Failure With Reduced Ejection Fraction: A Review
Sean P Murphy, Nasrien E Ibrahim, James L Januzzi
Page
of 11
Search research articles
Search
Showing results (11-20 of 109) with videos related to
Sort By:
Page
of 11
European Journal of Heart Failure
|
December 5, 2019
It is time for consistency in the use of biomarkers in heart failure clinical trials
James L Januzzi, Nasrien E Ibrahim
Journal of the American College of Cardiology
|
July 21, 2018
Are Guidelines Merely Suggestions?
John L Jefferies, Nasrien E Ibrahim
Current Heart Failure Reports
|
February 23, 2018
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study
Nasrien E Ibrahim, James L Januzzi
Journal of the American College of Cardiology
|
July 4, 2020
The Need to Innovate and Accelerate Clinical Trial Performance: BeAT the Clock
James L Januzzi, Nasrien E Ibrahim
JACC. Heart Failure
|
February 4, 2022
Personalizing Comprehensive Disease-Modifying Therapy: Obstacles and Opportunities
Ankeet S Bhatt, Muthiah Vaduganathan, Nasrien E Ibrahim
JACC. Cardiovascular Interventions
|
March 25, 2022
In Search of Cardiogenic Shock Equity, Equality, and Justice…
Alexander G Truesdell, Araba Ofosu-Somuah, Nasrien E Ibrahim
JACC. Heart Failure
|
May 8, 2024
The Quagmire of Prognostication in Heart Failure: The Case for Equity Through Modeled Predictions
Christy N Taylor, Nasrien E Ibrahim, Quentin R Youmans
JACC. Heart Failure
|
January 1, 2021
Promoting Health Equity in Heart Failure Amid a Pandemic
Ersilia M DeFilippis, Mitchell A Psotka, Nasrien E Ibrahim
Journal of Clinical Medicine
|
October 27, 2022
Physicians' Considerations and Practice Recommendations Regarding the Use of Sodium-Glucose Cotransporter-2 Inhibitors
Serge A Jabbour, Nasrien E Ibrahim, Christos P Argyropoulos
JAMA
|
August 5, 2020
Heart Failure With Reduced Ejection Fraction: A Review
Sean P Murphy, Nasrien E Ibrahim, James L Januzzi
Page
of 11